Document is current
Any future updates will be listed below
-
Authors
Cao, Bei
Ma, Tingting
Zhang, Yuqiang
Huang, Lei
Lin, Hui
Jiang, Huanhuan
Zhao, Yu
Geng, Yan
Yang, Yuanxun
Cao, Sumin
Li, Juan
-
Funding
Funding for this research was provided by:
Funding for Clinical Trials from Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School (2022-LCYJ-PY-19)
Natural Science Foundation of Nanjing University of Chinese Medicine (XZR2020055)
- License Information
-
More Information
Article History
Received: 21 February 2024
Accepted: 28 March 2024
First Online: 11 April 2024
Declarations
:
: The studies were conducted in accordance with the principles of the Declaration of Helsinki, the Good Clinical Practice guidelines of the International Council for Harmonisation, and any applicable national and local laws and regulations. The study protocols and informed consent documents were approved by the institutional review board (IRB) of Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School (IRB#: 2020-211-03). Informed consent was obtained from all individual participants included in the study.
: Author Yuqiang Zhang, Huanhuan Jiang and Sumin Cao were employees of Suzhong pharmaceutical group Co., LTD. This study received funding from Suzhong pharmaceutical group Co., LTD. The funder had the following involvement with the study including study design, data analysis and preparation of the manuscript. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants, or patents received or pending, or royalties.
